Daratumumab Market:Description
The daratumumab market is projected to grow at a CAGR of 6.2% by 2030, The global market was estimated at USD 3,568 million in 2017
A monoclonal antibody called daratumumab (Darzalex) is used as a targeted therapy to address the overexpressed cell surface glycoprotein seen on myeloma cells. Known as cluster of differentiation 38, this glycoprotein (CD38). An anti-cancer drug called Darzalex is used to treat myeloma. It works by attaching to the red blood cell's CD38 (RBC). The routine testing of clinically significant antibodies may be affected by daratumumab. The presence of any clinically significant antibodies is frequently concealed in people with pancreatic antibody panels, which will undermine daratumumab's ability to bind to CD38 on the surface of RBCs.
To request a sample copy or view summary of this report, click the Here@ https://healthcaremarketreports.com/sample-request/daratumumab-market/35862/
Market Insights
Our specialized reports offer information that is tailored to the unique needs of all the important stakeholders. Our reports provided with market evaluations that provide our clients with useful insights into market size, current competition, and factors. Reports also estimate the burden of common and unusual disease disorders based on prevalence and cost of care. Reports also include executive-level market blueprint and valuable ideas to help and establish effective expansion plans. Healthcare reports also provide in-depth examination of a market's research and development landscape. These data pointers and analysis provide in-depth research of pipeline product distribution by on clinical trial stage, therapeutic region, indication, and factors.
Daratumumab Market: Segment Analysis
Global Daratumumab Market: By Type
100mg Injection
400mg Injection
Global Daratumumab Market: By Application
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
Global Daratumumab Market:key players
Johnson＆Johnson
Key Regions & Countries
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Physiotherapy Devices market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Click Here, Purchase of Research Report@ https://healthcaremarketreports.com/purchase/daratumumab-market/35862/?license=single
FAQs
• What is the driving factor for the growth of this Market?
• How will the COVID-19 pandemic impact the demand and consumption of this Market?
• What is the major application area of this Market?
• Which geographical location is dominant in this Market?
• Which are the top industry players in this Market?
About Us
The healthcare industry is surely facing disruptions with global economies giving high importance to individual health. In this scenario, we expect our clients to get deep insights to power their innovations in the right direction. We have been keeping a close watch on the changes and modifications happening in the healthcare domain. As per our understanding, these alterations are active and unexampled.
Contact US
Healthcare Market Reports
99 WALL STREET, #2124 NEW YORK, NY 10005
sales@healthcaremarketreports.com
+1(929)-450-2887